Cargando…

Angiotensin-(1–7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation

Angiotensin (Ang) II mediates pathophysiologial changes in the kidney. Ang-(1–7) by interacting with the G protein-coupled receptor Mas may also have important biological activities. In this study, renal deficiency for Mas diminished renal damage in models of renal insufficiency as unilateral ureter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteban, Vanesa, Heringer-Walther, Silvia, Sterner-Kock, Anja, de Bruin, Ron, van den Engel, Sandra, Wang, Yong, Mezzano, Sergio, Egido, Jesus, Schultheiss, Heinz-Peter, Ruiz-Ortega, Marta, Walther, Thomas
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2672164/ https://www.ncbi.nlm.nih.gov/pubmed/19404405 http://dx.doi.org/10.1371/journal.pone.0005406

Ejemplares similares

Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents
por: Gembardt, Florian, et al.
Publicado: (2005)

Localization and expression of the Mas-related G-protein coupled receptor member D (MrgD) in the mouse brain
por: Hami, Javad, et al.
Publicado: (2021)

Improved Learning and Memory in Aged Mice Deficient in Amyloid β-Degrading Neutral Endopeptidase
por: Walther, Thomas, et al.
Publicado: (2009)

Angiotensin II Contributes to Renal Fibrosis Independently of Notch Pathway Activation
por: Lavoz, Carolina, et al.
Publicado: (2012)

Key fibrogenic mediators: old players. Renin–angiotensin system
por: Macconi, Daniela, et al.
Publicado: (2014)

Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process
por: Rodrigues Díez, Raúl, et al.
Publicado: (2010)

Angiotensin-(1-7) and Mas: A Brief History
por: Alenina, Natalia, et al.
Publicado: (2015)

Mas-Mediated Antioxidant Effects Restore the Functionality of Angiotensin Converting Enzyme 2-Angiotensin-(1–7)-Mas Axis in Diabetic Rat Carotid
por: Pernomian, Larissa, et al.
Publicado: (2014)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2012)

Angiotensin II during Experimentally Simulated Central Hypovolemia
por: Jensen, Theo Walther, et al.
Publicado: (2016)

Angiotensin-(1-7)/Angiotensin-Converting Enzyme 2/Mas Receptor Axis and Related Mechanisms
por: Ferreira, Anderson J., et al.
Publicado: (2012)

The expression of Mas-receptor of the renin–angiotensin system in the human eye
por: Vaajanen, A., et al.
Publicado: (2015)

Combining VEGF receptor inhibitors and angiotensin-(1–7) to target renal cell carcinoma
por: Walther, Thomas, et al.
Publicado: (2021)

Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
por: Flores-Muñoz, Monica, et al.
Publicado: (2012)

Further intracellular proteins and signaling pathways regulated by angiotensin-(1–7) in human endothelial cells
por: Meinert, Christian, et al.
Publicado: (2016)

Impact of angiotensin II type 1 and G-protein-coupled Mas receptor expression on the pulmonary performance of patients with idiopathic pulmonary fibrosis
por: Raupp, Débora, et al.
Publicado: (2020)

Renal vascular response to angiotensin 1-7 in rats: the role of Mas receptor
por: Nematbakhsh, Mehdi, et al.
Publicado: (2018)

Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis activates Akt signaling to ameliorate hepatic steatosis
por: Cao, Xi, et al.
Publicado: (2016)

Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Receptor Axis: Emerging Pharmacological Target for Pulmonary Diseases
por: Shenoy, Vinayak, et al.
Publicado: (2015)

Dual deficiency of angiotensin‐converting enzyme‐2 and Mas receptor enhances angiotensin II‐induced hypertension and hypertensive nephropathy
por: Ni, Jun, et al.
Publicado: (2020)

Angiotensin-(1-7)—A Potential Remedy for AKI: Insights Derived from the COVID-19 Pandemic
por: Heyman, Samuel N., et al.
Publicado: (2021)

T cells as key players for bone destruction in gouty arthritis?
por: Harre, Ulrike, et al.
Publicado: (2011)

VEGFR2 Blockade Improves Renal Damage in an Experimental Model of Type 2 Diabetic Nephropathy
por: Lavoz, Carolina, et al.
Publicado: (2020)

Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas
por: Kretschmer, Celine, et al.
Publicado: (2011)

Latent Transforming Growth Factor β-Binding Protein 4 Is Downregulated in Esophageal Cancer via Promoter Methylation
por: Bultmann, Insa, et al.
Publicado: (2013)

High glucose activates the alternative ACE2/Ang-(1-7)/Mas and APN/Ang IV/IRAP RAS axes in pancreatic β-cells
por: HÄRDTNER, CARMEN, et al.
Publicado: ( 201)

New Function for an Old Enzyme: NEP Deficient Mice Develop Late-Onset Obesity
por: Becker, Matthias, et al.
Publicado: (2010)

Genetic Deficiency in Neprilysin or Its Pharmacological Inhibition Initiate Excessive Stress-Induced Alcohol Consumption in Mice
por: Maul, Björn, et al.
Publicado: (2012)

New Cardiovascular and Pulmonary Therapeutic Strategies Based on the Angiotensin-Converting Enzyme 2/Angiotensin-(1–7)/Mas Receptor Axis
por: Ferreira, Anderson J., et al.
Publicado: (2012)

Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor
por: Murugan, Dharmani, et al.
Publicado: (2015)

Relationship between circulating levels of angiotensin-converting enzyme 2-angiotensin-(1–7)-MAS axis and coronary heart disease
por: Zhou, Xiaomin, et al.
Publicado: (2019)

Devil and angel in the renin–angiotensin system: ACE–angiotensin II–AT(1) receptor axis vs. ACE2–angiotensin-(1–7)–Mas receptor axis
por: Iwai, Masaru, et al.
Publicado: (2009)

Gremlin, A Potential Urinary Biomarker of Anca-Associated Crescentic Glomerulonephritis
por: Droguett, Alejandra, et al.
Publicado: (2019)

Biosynthetic Pathways and the Role of the Mas Receptor in the Effects of Angiotensin-(1–7) in Smooth Muscles
por: Fressatto de Godoy, Marcio Augusto, et al.
Publicado: (2012)

Angiotensin-(1-7)/Mas receptor as an antinociceptive agent in cancer-induced bone pain
por: Forte, Brittany L., et al.
Publicado: (2016)

The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
por: Xu, Juanjuan, et al.
Publicado: (2017)

Gonadotropin Stimulation Increases the Expression of Angiotensin-(1–7) and Mas Receptor in the Rat Ovary
por: Pereira, Virgínia M., et al.
Publicado: (2009)

Angiotensin-(1–7) alleviates acute lung injury by activating the Mas receptor in neutrophil
por: Wang, Liming, et al.
Publicado: (2022)

Radiofrequency Electromagnetic Fields Cause Non-Temperature-Induced Physical and Biological Effects in Cancer Cells
por: Wust, Peter, et al.
Publicado: (2022)

Key Players of Cisplatin Resistance: Towards a Systems Pharmacology Approach
por: Sarin, Navin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_87nq925jlhj3j44u0nta7uu0em